Skip to content
10-Q

Quarterly Report

STANDARD BIOTOOLS INC. LAB

0000950170-25-109388

← back to feed
Filed
Aug 15, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 15, 2025 382M sh
Shares Diluted Q2 2025 · Jun 30, 2025 380.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 379.37M sh
Shares Diluted Q2 2025 · Jun 30, 2024 372.33M sh
Shares Diluted Q2 2025 · Jun 30, 2024 333.23M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $0
Stock Repurchased Q2 2025 · Jun 30, 2024 $40.49M
Capex Q2 2025 · Jun 30, 2025 $6.94M
Capex Q2 2025 · Jun 30, 2024 $2.72M
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$50.95M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$101.53M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $158.62M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $166.73M
Stockholders Equity Q2 2025 · Jun 30, 2025 $424.54M
Stockholders Equity Q2 2025 · Mar 31, 2025 $454.6M
Stockholders Equity Q2 2025 · Dec 31, 2024 $471.72M
Stockholders Equity Q2 2025 · Jun 30, 2024 $510.26M
Stockholders Equity Q2 2025 · Mar 31, 2024 $577.32M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$148.05M
Current Liabilities Q2 2025 · Jun 30, 2025 $98.02M
Current Liabilities Q2 2025 · Dec 31, 2024 $65.9M
Total Liabilities Q2 2025 · Jun 30, 2025 $132.43M
Total Liabilities Q2 2025 · Dec 31, 2024 $140.62M
Current Assets Q2 2025 · Jun 30, 2025 $506.04M
Current Assets Q2 2025 · Dec 31, 2024 $375.88M
Total Assets Q2 2025 · Jun 30, 2025 $556.97M
Total Assets Q2 2025 · Dec 31, 2024 $612.35M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.09
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.16
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.12
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.37
Eps Basic Q2 2025 · Jun 30, 2025 −$0.09
Eps Basic Q2 2025 · Jun 30, 2025 −$0.16
Eps Basic Q2 2025 · Jun 30, 2024 −$0.12
Eps Basic Q2 2025 · Jun 30, 2024 −$0.37
Sga Expense Q2 2025 · Jun 30, 2025 $28.11M
Sga Expense Q2 2025 · Jun 30, 2025 $57.93M
Sga Expense restated Q2 2025 · Jun 30, 2024 $24.86M
Sga Expense restated Q2 2025 · Jun 30, 2024 $51.27M
Rd Expense Q2 2025 · Jun 30, 2025 $6.22M
Rd Expense Q2 2025 · Jun 30, 2025 $11.66M
Rd Expense restated Q2 2025 · Jun 30, 2024 $7.24M
Rd Expense restated Q2 2025 · Jun 30, 2024 $14.85M
Net Income Q2 2025 · Jun 30, 2025 −$33.46M
Net Income Q2 2025 · Jun 30, 2025 −$59.49M
Net Income Q2 2025 · Mar 31, 2025 −$26.03M
Net Income Q2 2025 · Jun 30, 2024 −$45.72M
Net Income Q2 2025 · Jun 30, 2024 −$77.88M
Net Income Q2 2025 · Mar 31, 2024 −$32.16M
Operating Income Q2 2025 · Jun 30, 2025 −$25.7M
Operating Income Q2 2025 · Jun 30, 2025 −$52.67M
Operating Income restated Q2 2025 · Jun 30, 2024 −$30.26M
Operating Income restated Q2 2025 · Jun 30, 2024 −$74.71M
Gross Profit Q2 2025 · Jun 30, 2025 $10.63M
Gross Profit Q2 2025 · Jun 30, 2025 $21.68M
Gross Profit restated Q2 2025 · Jun 30, 2024 $10.37M
Gross Profit restated Q2 2025 · Jun 30, 2024 $21.4M
Revenue Q2 2025 · Jun 30, 2025 $21.76M
Revenue Q2 2025 · Jun 30, 2025 $41.98M
Revenue restated Q2 2025 · Jun 30, 2024 $22.49M
Revenue restated Q2 2025 · Jun 30, 2024 $44.15M